To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

Despite the prevalence of cancer misinformation, exposure to it is not associated with greater fear of cancer recurrence or ...

DelveInsight's Castration-sensitive Prostate Cancer Market Insights report includes a comprehensive understanding of current treatment practices, CSPC emerging drugs, market share of individual ...

MIAMI, FL / ACCESS Newswire / January 9, 2026 / PromiCell, Inc. (the "Company"), a clinical-stage cellular immunotherapy ...

Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.

Accordingly, it is not surprising that a leading institution such as Johns Hopkins Medicine is at the forefront of this trend. John Hopkins University was an early participant in the clinical ...

The Centres for Disease Control and Prevention in the United States notes that frequent urination "often at night" serves as ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

Company finalizing preparations for end of January 2026 U.S. FDA Biologics License Application (BLA) submission for OST-HER2 ...

The nutritional value of powdered flax seeds stems from their omega-3 fats, fiber content and lignans, which enable people to ...

Radiation therapy has been a foundation of cancer care for more than a century. From early X-ray machines to today’s ...

NovaUCD-based medtech OncoAssure has signed a research collaboration agreement with the Icahn School of Medicine at Mount ...